>>On the Market
Healthcare Professionals: Please visit the Aggrastat product website.
Medicure is currently developing a transdermal delivery formulation of its lead drug
AGGRASTAT (tirofiban HCl).
January 28, 2014
MEDICURE REPORTS SECOND QUARTER FINANCIAL RESULTS... Read more
October 30, 2013
MEDICURE REPORTS FIRST QUARTER FINANCIAL RESULTS... Read more
October 11, 2013
MEDICURE ANNOUNCES APPROVAL OF RECOMMENDED DOSING REGIMEN FOR AGGRASTAT® Read more
Sign up to receive email updates such as Press Release nofications and other company news.